236 related articles for article (PubMed ID: 10996658)
1. Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism.
Gingras D; Pagé M; Annabi B; Béliveau R
Biochim Biophys Acta; 2000 Sep; 1497(3):341-50. PubMed ID: 10996658
[TBL] [Abstract][Full Text] [Related]
2. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells.
Annabi B; Lachambre MP; Bousquet-Gagnon N; Page M; Gingras D; Beliveau R
Biochim Biophys Acta; 2002 Jan; 1542(1-3):209-20. PubMed ID: 11853893
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate.
Heikkilä P; Teronen O; Hirn MY; Sorsa T; Tervahartiala T; Salo T; Konttinen YT; Halttunen T; Moilanen M; Hanemaaijer R; Laitinen M
J Surg Res; 2003 May; 111(1):45-52. PubMed ID: 12842447
[TBL] [Abstract][Full Text] [Related]
4. Necrosis induction in glioblastoma cells reveals a new "bioswitch" function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision.
Belkaid A; Fortier S; Cao J; Annabi B
Neoplasia; 2007 Apr; 9(4):332-40. PubMed ID: 17460777
[TBL] [Abstract][Full Text] [Related]
5. Calmodulin antagonists increase the expression of membrane-type-1 matrix metalloproteinase in human uterine cervical fibroblasts.
Ito A; Yamada M; Sato T; Sanekata K; Sato H; Seiki M; Nagase H; Mori Y
Eur J Biochem; 1998 Jan; 251(1-2):353-8. PubMed ID: 9492304
[TBL] [Abstract][Full Text] [Related]
6. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium.
Zhang J; Hampton AL; Nie G; Salamonsen LA
Biol Reprod; 2000 Jan; 62(1):85-94. PubMed ID: 10611071
[TBL] [Abstract][Full Text] [Related]
7. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
Monea S; Lehti K; Keski-Oja J; Mignatti P
J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
[TBL] [Abstract][Full Text] [Related]
8. Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.
Annabi B; Pilorget A; Bousquet-Gagnon N; Gingras D; Béliveau R
Biochem J; 2001 Oct; 359(Pt 2):325-33. PubMed ID: 11583578
[TBL] [Abstract][Full Text] [Related]
9. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form.
Stanton H; Gavrilovic J; Atkinson SJ; d'Ortho MP; Yamada KM; Zardi L; Murphy G
J Cell Sci; 1998 Sep; 111 ( Pt 18)():2789-98. PubMed ID: 9718371
[TBL] [Abstract][Full Text] [Related]
10. Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells.
Yan L; Moses MA; Huang S; Ingber DE
J Cell Sci; 2000 Nov; 113 ( Pt 22)():3979-87. PubMed ID: 11058085
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase.
Wu YI; Munshi HG; Sen R; Snipas SJ; Salvesen GS; Fridman R; Stack MS
J Biol Chem; 2004 Feb; 279(9):8278-89. PubMed ID: 14670950
[TBL] [Abstract][Full Text] [Related]
12. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.
Sato T; Iwai M; Sakai T; Sato H; Seiki M; Mori Y; Ito A
Br J Cancer; 1999 Jun; 80(8):1137-43. PubMed ID: 10376963
[TBL] [Abstract][Full Text] [Related]
14. Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells.
Maquoi E; Frankenne F; Noël A; Krell HW; Grams F; Foidart JM
Exp Cell Res; 2000 Dec; 261(2):348-59. PubMed ID: 11112341
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate-mediated regulation of matrix metalloproteinase-2 activation in normal human fibroblasts and fibrosarcoma cells.
Gervasi DC; Raz A; Dehem M; Yang M; Kurkinen M; Fridman R
Biochem Biophys Res Commun; 1996 Nov; 228(2):530-8. PubMed ID: 8920947
[TBL] [Abstract][Full Text] [Related]
17. Paradigmatic identification of MMP-2 and MT1-MMP activation systems in cardiac fibroblasts cultured as a monolayer.
Guo C; Jiang J; Elliott JM; Piacentini L
J Cell Biochem; 2005 Feb; 94(3):446-59. PubMed ID: 15534869
[TBL] [Abstract][Full Text] [Related]
18. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy.
Noda K; Ishida S; Inoue M; Obata K; Oguchi Y; Okada Y; Ikeda E
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2163-70. PubMed ID: 12714657
[TBL] [Abstract][Full Text] [Related]
19. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
[TBL] [Abstract][Full Text] [Related]
20. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
